Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation

被引:40
|
作者
Zheng, Bing [1 ]
Mao, Jia-Hui [2 ]
Li, Xiao-Qing [2 ]
Qian, Lin [1 ]
Zhu, Hua [1 ]
Gu, Dong-hua [1 ]
Pan, Xiao-dong [1 ]
机构
[1] Nantong Univ, Affiliated Hosp 2, Dept Urol, Nantong 226000, Peoples R China
[2] Nantong Univ, Sch Med, Dept Pathophysiol, Nantong, Peoples R China
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
关键词
DEPENDENT PROTEIN-KINASE; HUMAN TUMOR-CELLS; COLORECTAL-CANCER; AKT ACTIVATION; INHIBITOR; IDENTIFICATION; TRANSCRIPTION; APOPTOSIS; RAPAMYCIN; MUTATION;
D O I
10.1038/srep29415
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Here, we demonstrated that DNA-PKcs is over-expressed in multiple human renal cell carcinoma (RCC) tissues and in primary/established human RCCs. Pharmacological or genetic inhibition of DNA-PKcs suppressed proliferation of RCC cells. DNA-PKcs was in the complex of mTOR and SIN1, mediating mTORC2 activation and HIF-2 alpha expression in RCC cells. Inhibiting or silencing DNA-PKcs suppressed AKT Ser-473 phosphorylation and HIF-2 alpha expression. In vivo, DNA-PKcs knockdown or oral administration of the DNA-PKcs inhibitor NU-7441 inhibited AKT Ser-473 phosphorylation, HIF-2 alpha expression and 786-0 RCC xenograft growth in nude mice. We showed that miRNA-101 level was decreased in RCC tissues/cells, which could be responsible for DNA-PKcs overexpression and DNA-PKcs mediated oncogenic actions in RCC cells. We show that DNA-PKcs over-expression regulates mTORC2-AKT activation, HIF-2 alpha expression and RCC cell proliferation.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation
    Bing Zheng
    Jia-Hui Mao
    Xiao-Qing Li
    Lin Qian
    Hua Zhu
    Dong-hua Gu
    Xiao-dong Pan
    Scientific Reports, 6
  • [2] Inhibition of mTORC2 but not mTORC1 Up-Regulates E-Cadherin Expression and Inhibits Cell Motility by Blocking HIF-2α Expression in Human Renal Cell Carcinoma
    Maru, Shintaro
    Ishigaki, Yasuhito
    Shinohara, Nobuo
    Takata, Takanobu
    Tomosugi, Naohisa
    Nonomura, Katsuya
    JOURNAL OF UROLOGY, 2013, 189 (05): : 1921 - 1929
  • [4] HIF-2α expression and metabolic signaling require ACSS2 in clear cell renal cell carcinoma
    Bacigalupa, Zachary A.
    Arner, Emily N.
    Vlach, Logan M.
    Wolf, Melissa M.
    Brown, Whitney A.
    Krystofiak, Evan S.
    Ye, Xiang
    Hongo, Rachel A.
    Landis, Madelyn
    Amason, Edith K.
    Beckermann, Kathryn E.
    Rathmell, W. Kimryn
    Rathmell, Jeffrey C.
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (12):
  • [5] Targeting renal cell carcinoma with a HIF-2 antagonist
    Chen, Wenfang
    Hill, Haley
    Christie, Alana
    Kim, Min Soo
    Holloman, Eboni
    Pavia-Jimenez, Andrea
    Homayoun, Farrah
    Ma, Yuanqing
    Patel, Nirav
    Yell, Paul
    Hao, Guiyang
    Yousuf, Qurratulain
    Joyce, Allison
    Pedrosa, Ivan
    Geiger, Heather
    Zhang, He
    Chang, Jenny
    Gardner, Kevin H.
    Bruick, Richard K.
    Reeves, Catherine
    Hwang, Tae Hyun
    Courtney, Kevin
    Frenkel, Eugene
    Sun, Xiankai
    Zojwalla, Naseem
    Wong, Tai
    Rizzi, James P.
    Wallace, Eli M.
    Josey, John A.
    Xie, Yang
    Xie, Xian-Jin
    Kapur, Payal
    McKay, Renee M.
    Brugarolas, James
    NATURE, 2016, 539 (7627) : 112 - +
  • [6] Prognostic value of CD147 and HIF-2α expression in localized clear cell renal cell carcinoma
    Li, Hao
    Zhang, Tian
    Zhang, Yang
    Wang, Pei
    Bian, Huijie
    Chen, Zhi-Nan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9394 - 9400
  • [7] Targeting HIF-2 Alpha in Renal Cell Carcinoma
    Ramsha Ahmed
    Moshe C. Ornstein
    Current Treatment Options in Oncology, 2023, 24 (9) : 1183 - 1198
  • [8] Targeting HIF-2 Alpha in Renal Cell Carcinoma
    Ahmed, Ramsha
    Ornstein, Moshe C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (09) : 1183 - 1198
  • [9] Targeting renal cell carcinoma with a HIF-2 antagonist
    Wenfang Chen
    Haley Hill
    Alana Christie
    Min Soo Kim
    Eboni Holloman
    Andrea Pavia-Jimenez
    Farrah Homayoun
    Yuanqing Ma
    Nirav Patel
    Paul Yell
    Guiyang Hao
    Qurratulain Yousuf
    Allison Joyce
    Ivan Pedrosa
    Heather Geiger
    He Zhang
    Jenny Chang
    Kevin H. Gardner
    Richard K. Bruick
    Catherine Reeves
    Tae Hyun Hwang
    Kevin Courtney
    Eugene Frenkel
    Xiankai Sun
    Naseem Zojwalla
    Tai Wong
    James P. Rizzi
    Eli M. Wallace
    John A. Josey
    Yang Xie
    Xian-Jin Xie
    Payal Kapur
    Renée M. McKay
    James Brugarolas
    Nature, 2016, 539 : 112 - 117
  • [10] CONSEQUENCES OF HIF1A OVER-EXPRESSION IN RENAL CELL CARCINOMA AND BONE METASTASES
    Szendroi, A.
    Szasz, A. M.
    Kardos, M.
    Tokes, A. M.
    Idan, R.
    Romics, I
    Szendroi, M.
    Timar, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 236 - 236